前臨床CROの世界市場レポート 2025年

前臨床CRO市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で90億6,000万米ドルに成長します。予測期間の成長は、個別化医療の増加、希少疾患や希少疾病治療薬への注力、バイオ医薬品におけるアウトソーシングの増加、バイオマーカー研究の重視、実臨床でのエビデンス作成の需要などに起因すると考えられます。予測期間における主な動向には、人工知能（AI）の統合、腫瘍学研究の拡大、オミックス技術の進歩、高度なin vitroおよびin vivoモデル、トランスレーショナルリサーチのための共同研究などが含まれます。

前臨床試験に対する需要の高まりは、今後の前臨床試験受託機関（CRO）市場の拡大を促進すると予測されます。前臨床試験には、ヒトのボランティアが被験者として関与する前に、医薬品や治療法について実施される研究が含まれます。このような調査は、革新的な医療機器、処方薬、診断薬などを対象とすることが多く、主にファースト・イン・ヒト研究のための安全な初期投与量を決定し、製品の潜在的な毒性を評価することを目的としています。前臨床試験は医薬品開発に不可欠であり、その重要性は新薬の安全性と有効性への注目が高まるにつれて高まっています。例えば、2024年2月、米国に本社を置き、ヘルスケアテクノロジーおよび臨床研究分野にサービスを提供するIQVIA社は、2023年に臨床開発の生産性が向上し、合計69の新規活性物質（NAS）が世界で上市されたと報告しました。

アウトソーシングサービスに対するニーズの高まりは、今後数年間の前臨床CRO市場成長の原動力となると思われます。アウトソーシングサービスとは、第三者ベンダーと契約し、特定の業務や作業を管理することです。前臨床研究の複雑さは増加の一途をたどっており、製薬企業やバイオテクノロジー企業では社内に必ずしも存在しない専門的なスキルや専門知識が必要とされています。前臨床CROへのアウトソーシングにより、企業は社内で能力を高める負担を負うことなく必要な専門知識を利用することができ、前臨床研究を確実に完了させながら中核的な事業活動に集中することができます。2023年4月、BioPlan Associates Inc.の調査によると、バイオメーカーの84.6%が分析試験を、74.5%が毒性試験をアウトソーシングしていることが明らかになった。このことは、アウトソーシングサービスへの依存度が高まっていることを裏付けており、前臨床CRO市場の上昇軌道に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界前臨床CRO PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の前臨床CRO市場：成長率分析
• 世界の前臨床CRO市場の実績：規模と成長, 2019-2024
• 世界の前臨床CRO市場の予測：規模と成長, 2024-2029, 2034F
• 世界前臨床CRO総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の前臨床CRO市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ分析とDMPK研究
• 毒性試験
• 化合物管理
• 化学
• 安全性薬理学
• その他のサービス
• 世界の前臨床CRO市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 患者由来オルガノイド（PDO）モデル
• 患者由来異種移植モデル
• 世界の前臨床CRO市場動物モデルによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小動物モデル
• 大型動物モデル
• 世界の前臨床CRO市場モデルシステム別、実績と予測, 2019-2024, 2024-2029F, 2034F
• In vivo
• In vitro（体外）
• 世界の前臨床CRO市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 政府機関および学術機関
• 医療機器企業
• その他のエンドユーザー
• 世界の前臨床CRO市場、バイオ分析とDMPK研究のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物動態研究
• 薬力学研究
• 薬物代謝研究
• 世界の前臨床CRO市場毒性試験の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性毒性試験
• 慢性毒性試験
• 生殖毒性試験
• 世界の前臨床CRO市場、化合物管理のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サンプル管理
• 在庫管理
• 処方サービス
• 世界の前臨床CRO市場、化学のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品化学
• 分析化学
• 合成化学
• 世界の前臨床CRO市場、安全性薬理学のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管安全性研究
• 中枢神経系安全性研究
• 呼吸器安全性研究
• 世界の前臨床CRO市場、その他のサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 規制コンサルティング
• プロジェクト管理
• データ管理サービス

第7章 地域別・国別分析

• 世界の前臨床CRO市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の前臨床CRO市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 前臨床CRO市場：競合情勢
• 前臨床CRO市場：企業プロファイル
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • PRA Health Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Wuxi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Medpace Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Laboratory Corporation of America Holdings
• SGA SA
• Intertek Group plc
• Crown Bioscience International
• Cynbiose
• AmplifyBio LLC
• Vivotecnia SL
• Simavita Ltd.
• BioEmission Technology Solutions
• Altasciences Company Inc.
• Global Center For Medical Innovation
• Pharmaceutical Product Development LLC
• Parexel International Corporation
• Envigo RMS Holding Corporation
• Veeda Clinical Research Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 前臨床CRO市場2029：新たな機会を提供する国
• 前臨床CRO市場2029：新たな機会を提供するセグメント
• 前臨床CRO市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Preclinical Contract Research Organizations (CROs) play a crucial role as indispensable support entities, providing essential expertise in research and development to guide drug candidates through the animal testing phase and advance them toward the clinical stage. Their significance lies in aiding medical product producers in demonstrating the safety and efficacy of their products in animals that closely mimic human anatomy, adhering to FDA standards. This process is a prerequisite before initiating clinical trials or human applications.

The services offered by preclinical CROs cover a wide spectrum, including bioanalysis and DMPK studies, toxicology testing, compound management, chemistry, safety pharmacology, and more. A notable advancement in this domain is the adoption of patient-derived organoids (PDOs), which are small three-dimensional cell cultures created from a patient's cancer cells. Substantial investments and experimental validation efforts have been dedicated to PDOs, presenting promising therapeutic alternatives for diagnosing complex diseases. The repertoire of preclinical CRO services encompasses various models, such as the patient-derived organoid (PDO) model and patient-derived xenograft model, applicable to both small and large animal models. These model systems, spanning In Vivo and In Vitro approaches, find applications among biopharmaceutical companies, government and academic institutes, medical device companies, and other stakeholders.

The preclinical CRO market research report is one of a series of new reports from The Business Research Company that provides preclinical CRO market statistics, including preclinical CRO industry global market size, regional shares, competitors with an preclinical CRO market share, detailed preclinical CRO market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical CRO industry. This preclinical CRO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical CRO market size has grown strongly in recent years. It will grow from$5.7 billion in 2024 to $6.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to demand for faster drug development, cost containment strategies, focus on core competencies, regulatory compliance requirements, globalization of clinical trials

The preclinical CRO market size is expected to see strong growth in the next few years. It will grow to $9.06 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rise in personalized medicine, focus on rare diseases and orphan drugs, increased outsourcing in biopharmaceuticals, emphasis on biomarker research, demand for real-world evidence generation. Major trends in the forecast period include integration of artificial intelligence (AI), expansion of oncology research, advances in omics technologies, advanced in vitro and in vivo models, collaboration for translational research.

The growing demand for preclinical trials is projected to drive the expansion of the preclinical contract research organization (CRO) market in the future. Preclinical trials involve studies conducted on medicines or treatments for a condition before human volunteers are involved as test subjects. These studies often encompass innovative medical devices, prescription medications, and diagnostics, primarily aiming to determine a safe initial dose for first-in-human research and assess any potential toxicity of the product. Preclinical trials are essential to drug development, and their significance is heightened by the increasing focus on the safety and efficacy of new drugs. For instance, in February 2024, IQVIA, a U.S.-based company serving the healthcare technology and clinical research sectors, reported that clinical development productivity improved in 2023, with a total of 69 novel active substances (NASs) launched globally, which is six more than the previous year, including 24 first-in-class launches in the U.S. Consequently, the rising demand for preclinical trials is fueling the growth of the preclinical CRO market.

The increasing need for outsourcing services is poised to be a driving force behind the growth of the preclinical CRO market in the coming years. Outsourcing services involve contracting with third-party vendors to manage specific business tasks or operations. The complexity of preclinical research is on the rise, requiring specialized skills and expertise not always available in-house for pharmaceutical and biotechnology companies. Outsourcing to preclinical CROs allows companies to access the necessary expertise without the burden of building internal capabilities, enabling them to focus on core business activities while ensuring the completion of preclinical research. In April 2023, a survey by BioPlan Associates Inc. revealed that 84.6% of biomanufacturers are outsourcing analytical testing, and 74.5% are outsourcing toxicity testing in 2023. This underscores the increasing reliance on outsourcing services, contributing to the upward trajectory of the preclinical CRO market.

Technological advancements are a prominent trend gaining momentum in the preclinical Contract Research Organization (CRO) market, with significant companies in the sector adopting innovative technologies to strengthen their market positions. In February 2023, BenchSci, a Canada-based AI solutions company specializing in preclinical Research and Development (R&D), introduced ASCEND, an end-to-end Software as a Service (SaaS) platform for preclinical drug discovery. Leveraging artificial intelligence, ASCEND accelerates the preclinical phase of drug development pipelines by deriving biological insights into the foundational aspects of diseases. BenchSci's machine learning technology is employed to extract experimental data from both internal and external sources, enabling a comparison of results using curated ontology datasets. This approach facilitates the creation of evidence-based maps illustrating the biological processes underlying various diseases.

Key players in the preclinical CRO landscape are actively engaging in collaborations and partnerships to enhance their service offerings. Strategic partnerships, characterized by structured affiliations through business agreements or contracts, are a focal point in this context. In February 2022, IonsGate Preclinical Services Inc., a Canada-based CRO specializing in preclinical research services, announced a partnership with Insilicotrials Technologies Srl, an Italy-based provider of specialized consultancy for clinical trial solutions. This collaborative effort aims to leverage innovative technologies to expedite drug discovery processes, enabling more comprehensive preclinical testing capable of identifying potential safety risks at earlier stages of development.

In June 2022, Asahi Kasei Medical Co. Ltd., a Japan-based chemical company, successfully completed the acquisition of Bionova Scientific, LLC, in an undisclosed transaction. This strategic acquisition enhances Asahi Kasei Medical's bioprocess business by integrating a biopharmaceutical Contract Development and Manufacturing Organization (CDMO). The move broadens their customer base, particularly among those engaged in the development of cutting-edge next-generation biopharmaceuticals. Bionova Scientific LLC, a US-based company, specializes in offering contract process development services and Good Manufacturing Practice (GMP)-compliant contract manufacturing services for biopharmaceutical firms.

Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical cro market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The preclinical CRO market includes revenues earned by entities through project management, information gathering, medical evaluations, maximum dose research, adherence to regulations, efficacy and safety reporting, and quality analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preclinical CRO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical cro market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical cro ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preclinical cro market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services
• 2) By Type: Patient Derived Organoid (PDO) Model; Patient Derived Xenograft Model
• 3) By Animal Model: Small Animal Model; Large Animal Model
• 4) By Model System: In Vivo; In Vitro
• 5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-users
• Subsegments:
• 1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies; Pharmacodynamics Studies; Drug Metabolism Studies
• 2) By Toxicology Testing: Acute Toxicity Testing; Chronic Toxicity Testing; Reproductive Toxicity Testing
• 3) By Compound Management: Sample Management; Inventory Management; Formulation Services
• 4) By Chemistry: Medicinal Chemistry; Analytical Chemistry; Synthetic Chemistry
• 5) By Safety Pharmacology: Cardiovascular Safety Studies; Central Nervous System Safety Studies; Respiratory Safety Studies
• 6) By Other Services: Regulatory Consulting; Project Management; Data Management Services
• Companies Mentioned: Eurofins Scientific SE; PRA Health Sciences Inc.; Wuxi AppTec Co. Ltd.; Medpace Holdings Inc.; Charles River Laboratories International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preclinical CRO Market Characteristics

3. Preclinical CRO Market Trends And Strategies

4. Preclinical CRO Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Preclinical CRO Growth Analysis And Strategic Analysis Framework

• 5.1. Global Preclinical CRO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Preclinical CRO Market Growth Rate Analysis
• 5.4. Global Preclinical CRO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Preclinical CRO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Preclinical CRO Total Addressable Market (TAM)

6. Preclinical CRO Market Segmentation

• 6.1. Global Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioanalysis and DMPK Studies
• Toxicology Testing
• Compound Management
• Chemistry
• Safety Pharmacology
• Other Services
• 6.2. Global Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Derived Organoid (PDO) Model
• Patient Derived Xenograft Model
• 6.3. Global Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Animal Model
• Large Animal Model
• 6.4. Global Preclinical CRO Market, Segmentation By Model System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vivo
• In Vitro
• 6.5. Global Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Government and Academic Institutes
• Medical Device Companies
• Other End-users
• 6.6. Global Preclinical CRO Market, Sub-Segmentation Of Bioanalysis and DMPK Studies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacokinetics Studies
• Pharmacodynamics Studies
• Drug Metabolism Studies
• 6.7. Global Preclinical CRO Market, Sub-Segmentation Of Toxicology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Toxicity Testing
• Chronic Toxicity Testing
• Reproductive Toxicity Testing
• 6.8. Global Preclinical CRO Market, Sub-Segmentation Of Compound Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Management
• Inventory Management
• Formulation Services
• 6.9. Global Preclinical CRO Market, Sub-Segmentation Of Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicinal Chemistry
• Analytical Chemistry
• Synthetic Chemistry
• 6.10. Global Preclinical CRO Market, Sub-Segmentation Of Safety Pharmacology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Safety Studies
• Central Nervous System Safety Studies
• Respiratory Safety Studies
• 6.11. Global Preclinical CRO Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Consulting
• Project Management
• Data Management Services

7. Preclinical CRO Market Regional And Country Analysis

• 7.1. Global Preclinical CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Preclinical CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preclinical CRO Market

• 8.1. Asia-Pacific Preclinical CRO Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Preclinical CRO Market

• 9.1. China Preclinical CRO Market Overview
• 9.2. China Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Preclinical CRO Market

• 10.1. India Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Preclinical CRO Market

• 11.1. Japan Preclinical CRO Market Overview
• 11.2. Japan Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Preclinical CRO Market

• 12.1. Australia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Preclinical CRO Market

• 13.1. Indonesia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Preclinical CRO Market

• 14.1. South Korea Preclinical CRO Market Overview
• 14.2. South Korea Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Preclinical CRO Market

• 15.1. Western Europe Preclinical CRO Market Overview
• 15.2. Western Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Preclinical CRO Market

• 16.1. UK Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Preclinical CRO Market

• 17.1. Germany Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Preclinical CRO Market

• 18.1. France Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Preclinical CRO Market

• 19.1. Italy Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Preclinical CRO Market

• 20.1. Spain Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Preclinical CRO Market

• 21.1. Eastern Europe Preclinical CRO Market Overview
• 21.2. Eastern Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Preclinical CRO Market

• 22.1. Russia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Preclinical CRO Market

• 23.1. North America Preclinical CRO Market Overview
• 23.2. North America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Preclinical CRO Market

• 24.1. USA Preclinical CRO Market Overview
• 24.2. USA Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Preclinical CRO Market

• 25.1. Canada Preclinical CRO Market Overview
• 25.2. Canada Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Preclinical CRO Market

• 26.1. South America Preclinical CRO Market Overview
• 26.2. South America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Preclinical CRO Market

• 27.1. Brazil Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Preclinical CRO Market

• 28.1. Middle East Preclinical CRO Market Overview
• 28.2. Middle East Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Preclinical CRO Market

• 29.1. Africa Preclinical CRO Market Overview
• 29.2. Africa Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Preclinical CRO Market Competitive Landscape And Company Profiles

• 30.1. Preclinical CRO Market Competitive Landscape
• 30.2. Preclinical CRO Market Company Profiles
  • 30.2.1. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. PRA Health Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Wuxi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medpace Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Preclinical CRO Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings
• 31.2. SGA SA
• 31.3. Intertek Group plc
• 31.4. Crown Bioscience International
• 31.5. Cynbiose
• 31.6. AmplifyBio LLC
• 31.7. Vivotecnia SL
• 31.8. Simavita Ltd.
• 31.9. BioEmission Technology Solutions
• 31.10. Altasciences Company Inc.
• 31.11. Global Center For Medical Innovation
• 31.12. Pharmaceutical Product Development LLC
• 31.13. Parexel International Corporation
• 31.14. Envigo RMS Holding Corporation
• 31.15. Veeda Clinical Research Ltd.

32. Global Preclinical CRO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preclinical CRO Market

34. Recent Developments In The Preclinical CRO Market

35. Preclinical CRO Market High Potential Countries, Segments and Strategies

• 35.1 Preclinical CRO Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Preclinical CRO Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Preclinical CRO Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer